JP2009544333A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009544333A5 JP2009544333A5 JP2009522035A JP2009522035A JP2009544333A5 JP 2009544333 A5 JP2009544333 A5 JP 2009544333A5 JP 2009522035 A JP2009522035 A JP 2009522035A JP 2009522035 A JP2009522035 A JP 2009522035A JP 2009544333 A5 JP2009544333 A5 JP 2009544333A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- homology
- fragment
- sequence number
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012634 fragment Substances 0.000 claims description 277
- 239000002773 nucleotide Substances 0.000 claims description 235
- 125000003729 nucleotide group Chemical group 0.000 claims description 235
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 133
- 102000039446 nucleic acids Human genes 0.000 claims description 59
- 108020004707 nucleic acids Proteins 0.000 claims description 59
- 150000007523 nucleic acids Chemical class 0.000 claims description 59
- 108090000623 proteins and genes Proteins 0.000 claims description 53
- 102000004169 proteins and genes Human genes 0.000 claims description 53
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 15
- 108010008038 Synthetic Vaccines Proteins 0.000 claims description 12
- 229940124551 recombinant vaccine Drugs 0.000 claims description 12
- 230000028993 immune response Effects 0.000 claims description 11
- 230000001939 inductive effect Effects 0.000 claims description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- 230000002238 attenuated effect Effects 0.000 claims description 6
- 244000052769 pathogen Species 0.000 claims description 6
- 230000001717 pathogenic effect Effects 0.000 claims description 5
- 206010046865 Vaccinia virus infection Diseases 0.000 claims description 4
- 229960005486 vaccine Drugs 0.000 claims description 4
- 208000007089 vaccinia Diseases 0.000 claims description 4
- 239000013612 plasmid Substances 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims 1
- 206010022000 influenza Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83386106P | 2006-07-28 | 2006-07-28 | |
| US83385606P | 2006-07-28 | 2006-07-28 | |
| US89035207P | 2007-02-16 | 2007-02-16 | |
| PCT/US2007/074769 WO2008014521A2 (en) | 2006-07-28 | 2007-07-30 | Improved vaccines and methods for using the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013019415A Division JP6097086B2 (ja) | 2006-07-28 | 2013-02-04 | 改良されたワクチンおよびそれを使用するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009544333A JP2009544333A (ja) | 2009-12-17 |
| JP2009544333A5 true JP2009544333A5 (https=) | 2011-09-01 |
Family
ID=38982433
Family Applications (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009522035A Pending JP2009544333A (ja) | 2006-07-28 | 2007-07-30 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2013019415A Active JP6097086B2 (ja) | 2006-07-28 | 2013-02-04 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2014208626A Active JP6186333B2 (ja) | 2006-07-28 | 2014-10-10 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2015225411A Active JP6356653B2 (ja) | 2006-07-28 | 2015-11-18 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2018043805A Withdrawn JP2018108110A (ja) | 2006-07-28 | 2018-03-12 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2020044717A Active JP7030347B2 (ja) | 2006-07-28 | 2020-03-13 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2020044718A Withdrawn JP2020103318A (ja) | 2006-07-28 | 2020-03-13 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2022045506A Ceased JP2022081665A (ja) | 2006-07-28 | 2022-03-22 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2024204927A Pending JP2025032154A (ja) | 2006-07-28 | 2024-11-25 | 改良されたワクチンおよびそれを使用するための方法 |
Family Applications After (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013019415A Active JP6097086B2 (ja) | 2006-07-28 | 2013-02-04 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2014208626A Active JP6186333B2 (ja) | 2006-07-28 | 2014-10-10 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2015225411A Active JP6356653B2 (ja) | 2006-07-28 | 2015-11-18 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2018043805A Withdrawn JP2018108110A (ja) | 2006-07-28 | 2018-03-12 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2020044717A Active JP7030347B2 (ja) | 2006-07-28 | 2020-03-13 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2020044718A Withdrawn JP2020103318A (ja) | 2006-07-28 | 2020-03-13 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2022045506A Ceased JP2022081665A (ja) | 2006-07-28 | 2022-03-22 | 改良されたワクチンおよびそれを使用するための方法 |
| JP2024204927A Pending JP2025032154A (ja) | 2006-07-28 | 2024-11-25 | 改良されたワクチンおよびそれを使用するための方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US8168769B2 (https=) |
| EP (7) | EP2594576B1 (https=) |
| JP (9) | JP2009544333A (https=) |
| KR (10) | KR102511874B1 (https=) |
| CN (3) | CN105132439A (https=) |
| AU (4) | AU2007278831B2 (https=) |
| CA (4) | CA2949851C (https=) |
| DK (2) | DK3037429T3 (https=) |
| ES (2) | ES2589013T3 (https=) |
| HK (1) | HK1218427A1 (https=) |
| MX (3) | MX346862B (https=) |
| WO (1) | WO2008014521A2 (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007278831B2 (en) * | 2006-07-28 | 2013-03-21 | The Trustees Of The University Of Pennsylvania | Improved vaccines and methods for using the same |
| US8926961B2 (en) * | 2007-10-03 | 2015-01-06 | Board Of Trustees Of The University Of Arkansas | HPV E6 protein T cell epitopes and uses thereof |
| EP2217064A4 (en) * | 2007-11-12 | 2012-10-03 | Univ Pennsylvania | NEW VACCINES FOR FIGHT AGAINST SEVERAL SUBTYPES OF INFLUENZA VIRUSES |
| CA2653478A1 (en) * | 2009-01-23 | 2010-07-23 | Gregg Martin | Automated wash system for industrial vehicles |
| US8795430B2 (en) | 2009-03-02 | 2014-08-05 | The Regents Of The University Of California | Method of improving surface morphology of (Ga,Al,In,B)N thin films and devices grown on nonpolar or semipolar (Ga,Al,In,B)N substrates |
| CN102821790A (zh) * | 2009-09-14 | 2012-12-12 | 宾夕法尼亚大学托管会 | 包含IL-15受体α和/或编码IL-15受体α的核酸分子的疫苗和免疫治疗剂,以及其使用方法 |
| US8298820B2 (en) | 2010-01-26 | 2012-10-30 | The Trustees Of The University Of Pennsylvania | Influenza nucleic acid molecules and vaccines made therefrom |
| CA2788902C (en) * | 2010-02-08 | 2019-09-03 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same |
| EP2536830B1 (en) | 2010-02-16 | 2019-07-17 | Ultimovacs AS | Polypeptides |
| US8932575B2 (en) | 2010-09-21 | 2015-01-13 | University Of Miami | Compositions and methods for inducing migration by dendritic cells and an immune response |
| WO2012040266A2 (en) * | 2010-09-24 | 2012-03-29 | University Of Miami | Gene-based adjuvants and compositions thereof to increase antibody production in response to gene-based vaccines |
| JP2013544504A (ja) * | 2010-10-11 | 2013-12-19 | ノバルティス アーゲー | 抗原送達プラットフォーム |
| CN114277038A (zh) * | 2011-10-12 | 2022-04-05 | 宾夕法尼亚大学理事会 | 用于人乳头状瘤病毒的疫苗及其使用方法 |
| KR20140116095A (ko) | 2011-12-12 | 2014-10-01 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | Mrsa pbp2a 및 이의 단편들을 포함하는 단백질, 이를 인코딩한 핵산, 및 mrsa 감염을 예방 및 치료하기 위한 조성물 및 그의 용도 |
| SG11201501646PA (en) * | 2012-09-07 | 2015-04-29 | Agency Science Tech & Res | Peptides and their uses |
| CN103172705B (zh) * | 2013-02-27 | 2014-08-20 | 北京大学人民医院 | 丙型肝炎病毒b细胞表位肽puhi16及其应用 |
| CN103102394B (zh) * | 2013-02-27 | 2014-06-25 | 北京大学人民医院 | 丙型肝炎病毒b细胞表位肽puhi49及其应用 |
| CN103113458B (zh) * | 2013-02-27 | 2014-08-20 | 北京大学人民医院 | 丙型肝炎病毒b细胞表位肽puhi34及其应用 |
| WO2014165291A1 (en) * | 2013-03-12 | 2014-10-09 | The Trustees Of The University Of Pennsylvania | Improved vaccines for human papilloma virus and methods for using the same |
| AU2014228405B2 (en) | 2013-03-15 | 2017-05-11 | The Trustees Of The University Of Pennsylvania | Cancer vaccines and methods of treatment using the same |
| KR20220061285A (ko) * | 2013-11-14 | 2022-05-12 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | HIV-1 EnV DNA 백신과 단백질 부스터 |
| MA40783A (fr) | 2014-10-03 | 2017-08-08 | Los Alamos Nat Security Llc | Vaccins contre le vih comprenant un ou plusieurs antigènes episensus de population |
| CA2974956A1 (en) * | 2015-01-29 | 2016-08-04 | The Trustees Of The University Of Pennsylvania | Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy |
| JP2019505512A (ja) | 2016-01-08 | 2019-02-28 | バッシボディ アクスイェ セルスカプ | 治療用抗癌ネオエピトープワクチン |
| MX2018009506A (es) * | 2016-02-05 | 2019-05-06 | Inovio Pharmaceuticals Inc | Vacunas contra el cáncer y métodos de tratamiento que las utilizan. |
| CN109069575A (zh) * | 2016-02-23 | 2018-12-21 | 毛里齐奥·扎内蒂 | 通用癌症疫苗 |
| KR20230167445A (ko) * | 2016-09-30 | 2023-12-08 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | Tert 면역원성 조성물 및 이를 이용한 치료 방법 |
| WO2018156106A1 (en) * | 2017-02-22 | 2018-08-30 | Ding Enyu | An mrna cancer vaccine encoding human gm-csf fused to multiple tandem epitopes |
| CN109142723B (zh) * | 2018-08-21 | 2021-07-13 | 苏州华益美生物科技有限公司 | 人类免疫缺陷病毒快速检测测试卡及其应用 |
| CN114761041A (zh) | 2019-07-16 | 2022-07-15 | 吉利德科学公司 | Hiv疫苗及其制备和使用方法 |
| WO2021202949A2 (en) * | 2020-04-02 | 2021-10-07 | Inovio Pharmaceuticals, Inc. | Compositions and methods for treating vulvar dysplasia |
| EP4277652A1 (en) | 2021-01-14 | 2023-11-22 | Gilead Sciences, Inc. | Hiv vaccines and methods of using |
Family Cites Families (83)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US21579A (en) | 1858-09-21 | Rotary valve fob steam-engines | ||
| US2579A (en) | 1842-04-21 | Flour-ing-mill combining a smut-machine with the scouring-stones | ||
| US2157994A (en) | 1937-11-08 | 1939-05-09 | Kelsey Hayes Wheel Co | Brake mechanism |
| US5077044A (en) | 1980-05-19 | 1991-12-31 | The Board Of Trustees Of The Leland Stanford Jr. University | Novel non-reverting shigella live vaccines |
| US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| US5338683A (en) | 1981-12-24 | 1994-08-16 | Health Research Incorporated | Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins |
| US5110587A (en) | 1981-12-24 | 1992-05-05 | Health Research, Incorporated | Immunogenic composition comprising synthetically modified vaccinia virus |
| US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| US4510245A (en) | 1982-11-18 | 1985-04-09 | Chiron Corporation | Adenovirus promoter system |
| ZA858044B (en) | 1984-11-01 | 1987-05-27 | American Home Prod | Oral vaccines |
| US5643579A (en) | 1984-11-01 | 1997-07-01 | American Home Products Corporation | Oral vaccines |
| US5036006A (en) | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| GB8508845D0 (en) | 1985-04-04 | 1985-05-09 | Hoffmann La Roche | Vaccinia dna |
| US5223424A (en) | 1985-09-06 | 1993-06-29 | Prutech Research And Development | Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence |
| US4790987A (en) | 1985-11-15 | 1988-12-13 | Research Corporation | Viral glycoprotein subunit vaccine |
| US5310668A (en) | 1986-06-20 | 1994-05-10 | Merck & Co., Inc. | Varicella-zoster virus as a live recombinant vaccine |
| US5242829A (en) | 1986-09-23 | 1993-09-07 | Therion Biologics Corporation | Recombinant pseudorabies virus |
| IL86583A0 (en) | 1987-06-04 | 1988-11-15 | Molecular Eng Ass | Vaccine containing a derivative of a microbe and method for the production thereof |
| US5387744A (en) | 1987-06-04 | 1995-02-07 | Washington University | Avirulent microbes and uses therefor: Salmonella typhi |
| US5294441A (en) | 1987-06-04 | 1994-03-15 | Washington University | Avirulent microbes and uses therefor: salmonella typhi |
| US5112749A (en) | 1987-10-02 | 1992-05-12 | Praxis Biologics, Inc. | Vaccines for the malaria circumsporozoite protein |
| JP3044062B2 (ja) | 1989-03-08 | 2000-05-22 | ヘルス・リサーチ・インク | 組換えポックスウイルス宿主選択系 |
| US5225336A (en) | 1989-03-08 | 1993-07-06 | Health Research Incorporated | Recombinant poxvirus host range selection system |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5591439A (en) | 1989-03-24 | 1997-01-07 | The Wistar Institute Of Anatomy And Biology | Recombinant cytomegalovirus vaccine |
| EP0465560B1 (en) | 1989-03-31 | 1996-06-05 | Washington University | VACCINES CONTAINING AVIRULENT phoP-TYPE MICROORGANISMS |
| EP0431668B1 (en) | 1989-12-04 | 1995-02-15 | Akzo Nobel N.V. | Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| US5294548A (en) | 1990-04-02 | 1994-03-15 | American Biogenetic Sciences, Inc | Recombianant Hepatitis a virus |
| WO1991018088A1 (en) | 1990-05-23 | 1991-11-28 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Adeno-associated virus (aav)-based eucaryotic vectors |
| US5462734A (en) | 1990-11-02 | 1995-10-31 | Wisconsin Alumni Research Foundation | Bovine herpesvirus vaccine and method of using same |
| US6183745B1 (en) * | 1990-12-12 | 2001-02-06 | The University Of Queensland | Subunit papilloma virus vaccine and peptides for use therein |
| KR100252371B1 (ko) * | 1990-12-12 | 2000-05-01 | 포터 더글라스 | 서브유니트 파필로마비루스 백신 및 그들에 사용하기 위한 펩티드 |
| US5240703A (en) | 1991-03-01 | 1993-08-31 | Syntro Corporation | Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
| US6034298A (en) | 1991-08-26 | 2000-03-07 | Prodigene, Inc. | Vaccines expressed in plants |
| US5955088A (en) | 1992-02-03 | 1999-09-21 | Cedars-Sinai Medical Center | Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins |
| US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| US5981505A (en) | 1993-01-26 | 1999-11-09 | The Trustees Of The University Of Pennsylvania | Compositions and methods for delivery of genetic material |
| AU675702B2 (en) | 1993-01-26 | 1997-02-13 | Leslie R. Coney | Compositions and methods for delivery of genetic material |
| EP0708659A4 (en) | 1993-06-07 | 2000-08-23 | Genentech Inc | HIV ENVELOPE POLYPEPTIDES |
| US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
| US6156319A (en) | 1994-07-25 | 2000-12-05 | The Trustees Of The University Of Pennsylvania | Soluble herpesvirus glycoprotein complex vaccine |
| NL9401820A (nl) | 1994-11-02 | 1996-06-03 | Meyn Maschf | Inrichting voor het bewerken van aan zijn poten opgehangen gevogelte. |
| AUPN015794A0 (en) * | 1994-12-20 | 1995-01-19 | Csl Limited | Variants of human papilloma virus antigens |
| US5703655A (en) | 1995-03-24 | 1997-12-30 | U S West Technologies, Inc. | Video programming retrieval using extracted closed caption data which has been partitioned and stored to facilitate a search and retrieval process |
| US5962428A (en) | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
| US5650309A (en) | 1995-05-16 | 1997-07-22 | The Regents Of The University Of California | Viral vectors |
| US5698202A (en) | 1995-06-05 | 1997-12-16 | The Wistar Institute Of Anatomy & Biology | Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier |
| US7585622B1 (en) * | 1996-10-01 | 2009-09-08 | Geron Corporation | Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
| EP0932686A2 (en) * | 1996-10-01 | 1999-08-04 | Geron Corporation | Telomerase reverse transcriptase |
| CN1240480A (zh) * | 1996-10-18 | 2000-01-05 | 坎吉有限公司 | 运送和表达干扰素－α核酸的方法和组合物 |
| AUPO517897A0 (en) * | 1997-02-19 | 1997-04-11 | Csl Limited | Chelating immunostimulating complexes |
| DE19720914A1 (de) * | 1997-05-16 | 1998-11-19 | Boehringer Mannheim Gmbh | Verfahren zum Nachweis von HIV-Antikörpern und dazu verwendete Antigene |
| KR100581990B1 (ko) * | 1997-07-01 | 2006-05-23 | 캄비아 바이오시스템즈 엘엘씨 | 척추 동물 텔로머라제 유전자 및 단백질과 이의 용도 |
| GB9717953D0 (en) | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
| AU752725B2 (en) | 1997-09-18 | 2002-09-26 | Trustees Of The University Of Pennsylvania, The | Attenuated vif DNA immunization cassettes for genetic vaccines |
| US6589529B1 (en) | 1998-10-30 | 2003-07-08 | Children's Hospital Medical Center | Rotavirus subunit vaccine |
| FR2794370B1 (fr) * | 1999-06-03 | 2003-10-17 | Biovector Therapeutics | Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination |
| FR2794368A1 (fr) * | 1999-10-07 | 2000-12-08 | Biovector Therapeutics | Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination |
| US7026443B1 (en) * | 1999-12-10 | 2006-04-11 | Epimmune Inc. | Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions |
| US7488484B2 (en) | 2000-07-14 | 2009-02-10 | The Trustees Of The University Of Pennsylvania | Nucleic acid expression cassette encoding an HIV polyprotein comprising the ancillary gene products Vif, Vpu, and Nef |
| AU1152402A (en) * | 2000-10-04 | 2002-04-15 | Univ Pennsylvania | Highly expressible genes |
| EP1195438A1 (en) * | 2000-10-06 | 2002-04-10 | Rijksuniversiteit te Groningen | Genetic immunisation against cervical carcinoma |
| US20040171081A1 (en) * | 2001-11-23 | 2004-09-02 | Abraham Mittelman | Antigens |
| US7245963B2 (en) | 2002-03-07 | 2007-07-17 | Advisys, Inc. | Electrode assembly for constant-current electroporation and use |
| CN1468956A (zh) * | 2002-07-15 | 2004-01-21 | 杨 琴 | 高效表达治疗肿瘤的抗体的重组病毒及其用途 |
| CN1315536C (zh) * | 2002-09-13 | 2007-05-16 | 李进 | 肿瘤抗原疫苗及其制备方法和疫苗组合物 |
| DE60332377D1 (de) * | 2002-10-21 | 2010-06-10 | Eisai Inc | Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden |
| CN1453361A (zh) * | 2003-05-30 | 2003-11-05 | 中国科学院上海生命科学研究院 | 一种抗癌靶向可调控基因－病毒的构建方法 |
| NZ570709A (en) | 2003-06-13 | 2010-04-30 | Univ Pennsylvania | Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same |
| CA2539325C (en) * | 2003-09-17 | 2016-03-22 | Duke University | Consensus/ancestral immunogens |
| WO2005028634A2 (en) * | 2003-09-18 | 2005-03-31 | Emory University | Improved mva vaccines |
| JP2007528838A (ja) * | 2003-12-24 | 2007-10-18 | ライデン ユニバーシティ メディカル センター | 腫瘍特異的ワクチンとしての合成タンパク質 |
| AU2005222776A1 (en) * | 2003-12-31 | 2005-09-29 | Genimmune N.V. | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| EP1732615A4 (en) * | 2004-03-25 | 2009-09-16 | Kentucky Bioproc Llc | PREPARATION OF PEPTIDES IN PLANTS AS VIRUS SHELL PROTEIN FUSION |
| CN1775802A (zh) * | 2004-11-17 | 2006-05-24 | 宋硕 | 人类乳头瘤病毒免疫原性多肽、其制备方法及应用 |
| ATE541938T1 (de) * | 2005-04-29 | 2012-02-15 | Univ Cape Town | Expression viraler proteine in pflanzen |
| EP1909829A4 (en) * | 2005-07-19 | 2009-11-11 | Dow Global Technologies Inc | RECOMBINANT GRIP VACCINES |
| AU2007278831B2 (en) * | 2006-07-28 | 2013-03-21 | The Trustees Of The University Of Pennsylvania | Improved vaccines and methods for using the same |
| EP2076531B1 (en) * | 2006-10-12 | 2011-11-23 | Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. | Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof |
| GB2504774A (en) | 2012-08-10 | 2014-02-12 | Munster Simms Eng Ltd | Diaphragm pump with integral motor housing and rear pump housing |
| KR20140137679A (ko) | 2013-05-23 | 2014-12-03 | 삼성전자주식회사 | 카드 소켓 장치 |
-
2007
- 2007-07-30 AU AU2007278831A patent/AU2007278831B2/en active Active
- 2007-07-30 ES ES13187666.6T patent/ES2589013T3/es active Active
- 2007-07-30 US US12/375,518 patent/US8168769B2/en active Active
- 2007-07-30 WO PCT/US2007/074769 patent/WO2008014521A2/en not_active Ceased
- 2007-07-30 KR KR1020217039157A patent/KR102511874B1/ko active Active
- 2007-07-30 DK DK16156199.8T patent/DK3037429T3/en active
- 2007-07-30 EP EP12197840.7A patent/EP2594576B1/en active Active
- 2007-07-30 CA CA2949851A patent/CA2949851C/en active Active
- 2007-07-30 CN CN201510500682.7A patent/CN105132439A/zh active Pending
- 2007-07-30 KR KR1020247035070A patent/KR20240159010A/ko not_active Ceased
- 2007-07-30 KR KR1020177004941A patent/KR101848867B1/ko active Active
- 2007-07-30 DK DK07840587.5T patent/DK2049559T3/da active
- 2007-07-30 EP EP07840587A patent/EP2049559B1/en active Active
- 2007-07-30 EP EP21163008.2A patent/EP3907232B1/en active Active
- 2007-07-30 MX MX2015000975A patent/MX346862B/es unknown
- 2007-07-30 ES ES16156199T patent/ES2706501T3/es active Active
- 2007-07-30 CA CA3057039A patent/CA3057039C/en active Active
- 2007-07-30 KR KR1020097004232A patent/KR101562888B1/ko active Active
- 2007-07-30 MX MX2009001099A patent/MX2009001099A/es active IP Right Grant
- 2007-07-30 CN CN200780036389.3A patent/CN101679475B/zh active Active
- 2007-07-30 KR KR1020187010028A patent/KR101999376B1/ko active Active
- 2007-07-30 CN CN201510501034.3A patent/CN105063064B/zh active Active
- 2007-07-30 KR KR1020237009029A patent/KR20230042399A/ko not_active Ceased
- 2007-07-30 EP EP16156199.8A patent/EP3037429B1/en active Active
- 2007-07-30 KR KR1020147035344A patent/KR101609235B1/ko active Active
- 2007-07-30 CA CA2659262A patent/CA2659262C/en active Active
- 2007-07-30 KR KR1020167007633A patent/KR101710981B1/ko active Active
- 2007-07-30 EP EP18196529.4A patent/EP3489251B1/en not_active Not-in-force
- 2007-07-30 JP JP2009522035A patent/JP2009544333A/ja active Pending
- 2007-07-30 CA CA3184778A patent/CA3184778A1/en active Pending
- 2007-07-30 KR KR1020197019662A patent/KR102173636B1/ko active Active
- 2007-07-30 KR KR1020207031173A patent/KR102334637B1/ko active Active
- 2007-07-30 EP EP13187666.6A patent/EP2708549B1/en active Active
- 2007-07-30 EP EP24158688.2A patent/EP4400510A3/en active Pending
-
2009
- 2009-01-28 MX MX2013005334A patent/MX340880B/es unknown
-
2012
- 2012-04-27 US US13/458,013 patent/US8697084B2/en active Active
-
2013
- 2013-02-04 JP JP2013019415A patent/JP6097086B2/ja active Active
- 2013-03-18 AU AU2013201592A patent/AU2013201592B2/en active Active
- 2013-12-23 US US14/139,729 patent/US9376471B2/en active Active
- 2013-12-23 US US14/139,660 patent/US9290546B2/en active Active
-
2014
- 2014-10-10 JP JP2014208626A patent/JP6186333B2/ja active Active
-
2015
- 2015-11-18 JP JP2015225411A patent/JP6356653B2/ja active Active
-
2016
- 2016-06-02 HK HK16106306.8A patent/HK1218427A1/zh unknown
-
2018
- 2018-03-12 JP JP2018043805A patent/JP2018108110A/ja not_active Withdrawn
-
2020
- 2020-03-13 JP JP2020044717A patent/JP7030347B2/ja active Active
- 2020-03-13 JP JP2020044718A patent/JP2020103318A/ja not_active Withdrawn
-
2022
- 2022-03-22 JP JP2022045506A patent/JP2022081665A/ja not_active Ceased
-
2024
- 2024-01-02 AU AU2024200014A patent/AU2024200014B2/en active Active
- 2024-11-25 JP JP2024204927A patent/JP2025032154A/ja active Pending
-
2026
- 2026-02-26 AU AU2026201472A patent/AU2026201472A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009544333A5 (https=) | ||
| JP2012515557A5 (https=) | ||
| JP2014507146A5 (https=) | ||
| HRP20191594T1 (hr) | Poticanje imunosnog odgovora | |
| JP2009540801A5 (https=) | ||
| JP2015501840A5 (https=) | ||
| JP2009523422A5 (https=) | ||
| JP2014500724A5 (https=) | ||
| JP2019506175A5 (https=) | ||
| JP2013507907A5 (https=) | ||
| JP2019530462A5 (https=) | ||
| JP2014534202A5 (https=) | ||
| FI3872085T3 (fi) | Esimuotoiset virussekvenssit ja niiden käytöt | |
| JP2016520530A5 (https=) | ||
| JP2015501656A5 (https=) | ||
| MX358725B (es) | Antigenos prostaticos de consenso, molecula de acido nucleico que los codifica y vacuna y usos que los comprenden. | |
| JP2014504851A5 (https=) | ||
| JP2020536489A5 (https=) | ||
| JP2015509707A5 (https=) | ||
| JP2011517938A5 (https=) | ||
| WO2006037038B1 (en) | Optimized vaccines to provide protection against ebola and other viruses | |
| WO2014205579A4 (en) | Modified matrix proteins of vesicular stomatitis virus | |
| JP2014519817A5 (https=) | ||
| JP2012516140A5 (https=) | ||
| JP2013518599A5 (https=) |